IPX — IperionX Limited stock price, charts and financials

NASDAQ·Basic Materials·Industrial Materials·USA

Latest market price

25.75

+0.67+2.65%

Overview Short InterestFilings

IPXQT35IperionX Limited·NASDAQ

Overview Short InterestFilings

25.75+2.65%

Loading chart...

Signal & projected range

Short-squeeze setupHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

GSM+3.90%$4.67 NAK-1.17%$1.69 NB+1.12%$5.42 UAMY-1.31%$6.76 LAC+1.24%$3.27 LAR+4.54%$7.25 CRML-3.90%$6.97 CMP-1.63%$26.91

Snapshot

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	3.36M	Perf Week	20.92%

Market Cap	880.81M	Forward P/E	25.67	EPS next Y	0.98	Insider Trans	4.01%	Shs Float	2.66M	Perf Month	5.64%

Enterprise Value	819.40M	PEG	0.30	EPS next Q	-0.07	Inst Own	-	Short Float	31.82%	Perf Quarter	-38.31%

Income	-38.14M	P/S	0.00	EPS this Y	-	Inst Trans	-	Short Ratio	2.87	Perf Half Y	-40.50%

Sales	0.00	P/B	7.56	EPS next Y	346.33%	ROA	-27.41%	Short Interest	845.62K	Perf YTD	-30.67%

Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-35.30%	52W High	63.08 -59.17%	Perf Year	-37.37%

Cash/sh	-	P/FCF	-	EPS past 3/5Y	-	ROIC	-32.99%	52W Low	20.62 24.89%	Perf 3Y	251.40%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-	Gross Margin	0.00%	Volatility	5.53% 5.65%	Perf 5Y	-

Dividend TTM	-	EV/Sales	0.00	EPS Y/Y TTM	73.00%	Oper. Margin	0.00%	ATR (14)	1.66	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	4.00	Sales Y/Y TTM	-	Profit Margin	0.00%	RSI (14)	52.04	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	4.03	EPS Q/Q	23.08%	SMA20	8.99%	Beta	3.06	Target Price	48.67

Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	-	SMA50	-12.56%	Rel Volume	0.60	Prev Close	25.09

Employees	28	LT Debt/Eq	0.03	Earnings	Sep 23	SMA200	-30.17%	Avg Volume	300.06K	Price	25.75

IPO Date	Jun 21, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	79.59% -	Net Debt/EBITDA	1.74	Volume	181,389	Change	2.65%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-05-26	Reiterated	Roth Capital	Buy	$75 → $53
Apr-28-26	Reiterated	Industrial Alliance Securities		$60 → $53
Mar-27-26	Initiated	BTIG	Buy	$40

Latest News

Aug-04-26

Aug-04-2608:05PM

IperionX Targets 200-Ton Titanium Run Rate as U.S. Supply Chain Takes Shapemarketbeat.com

Aug-03-26

Aug-03-2608:33AM

IperionX To Redomicile The U.S. Through A Texas-Incorporated Ultimate Parent CompanyBenzinga

08:30AM

IperionX Advances American Titanium Growth Strategy With Proposed U.S. Redomiciliation and Board Appointmentglobenewswire.com

Jul-31-26

Jul-31-2608:30AM

IperionX Webinar – Investor Updateglobenewswire.com

Jul-30-26

Jul-30-2608:30AM

IperionX – June 2026 Quarterly Reportglobenewswire.com

Jul-26-26

Jul-26-2602:01AM

IperionX (NASDAQ:IPX) Sets New 1-Year Low – Should You Sell?defenseworld.net

Jul-23-26

Jul-23-2602:35PM

Top 4 Small-Cap Stocks In The Gold Industry With The Highest ROEBenzinga

Jul-22-26

Jul-22-2610:54AM

IPX1031 Releases Annual List of Top 1031 Exchange Misconceptions for 2026globenewswire.com

Jul-21-26

Jul-21-2602:18PM

Austin Gold Filed Form F-3 For At-The-Market Offering Of Up To $7.5M In Common Shares Under Agreement With H.C. Wainwright And Roth Capital PartnersBenzinga

Jul-08-26

Jul-08-2612:50PM

Scully Royalty shares are trading higher after the company provided corporate updates and announced actions seeking to maximize shareholder value.Benzinga

Jul-07-26

Jul-07-2607:51PM

IperionX Announces Pricing of Public Offering of American Depositary Sharesglobenewswire.com

Jul-02-26

Jul-02-2612:30PM

IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply ChainYahoo

Jul-01-26

Jul-01-2608:30AM

IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applicationsglobenewswire.com

Jun-29-26

Jun-29-2603:00AM

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuationsglobenewswire.com

Jun-24-26

Jun-24-2608:03AM

FedEx, Cerebras Systems And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga

Company

IperionX Limited primarily focuses on discovering and developing mineral resource sites. The company's geological surveys seek out valuable deposits, specifically targeting epithermal and replacement-style precious and base metals, alongside titanium, rare earth elements, silica sand, and zircon. It possesses complete ownership of the Milford project, which consists of 101 claims within Utah, United States. Additionally, IperionX fully controls the Titan project, an approximately 6,000-acre area located in Tennessee, United States. Established in 2017, the enterprise was initially known as Hyperion Metals Limited, subsequently changing its name to IperionX Limited in February 2022. Its corporate headquarters are based in Charlotte, North Carolina.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	FY 2025 6/30/2025	FY 2024 6/30/2024	FY 2023 6/30/2023	FY 2022 6/30/2022	FY 2021 6/30/2021	FY 2020 6/30/2020	FY 2019 6/30/2019	FY 2018 6/30/2018	FY 2017 6/30/2017
Total Revenue	0	0	0	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	2	1	1	—	—	—	—	—	—
Gross Profit	-2	-1	-1	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	26	13	17	—	—	—	—	—	—
Research and Development	13	9	8	—	—	—	—	—	—
Other Operating Expense	-1	0	1	—	—	—	—	—	—
Operating Income	-39	-22	-18	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	4	1	0	—	—	—	—	—	—
Net Income Before Taxes	-35	-22	-17	—	—	—	—	—	—
Income Taxes	0	0	0	—	—	—	—	—	—
Consolidated Net Income	-35	-22	-17	—	—	—	—	—	—
Net Income From Continuing Operations	-35	-22	-17	—	—	—	—	—	—
Net Income	-35	-22	-17	—	—	—	—	—	—
EPS (Recurring)	-1.20	-1.00	-1.50	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-1.20	-1.00	-1.50	—	—	—	—	—	—
EPS (Diluted)	-1.20	-1.00	-1.50	—	—	—	—	—	—
EBITDA	-38	-22	-17	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	—	—	—	—	—	—	—	—	—
Gross Margin	—	—	—	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—	—	—	—
Net Margin	—	—	—	—	—	—	—	—	—
Shares Outstanding	29	22	17	—	—	—	—	—	—
Market Capitalization	914	306	124	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wyse Beverly	Director	Jul 15 '26	Option Exercise	0.87	106,093	92,301	745,868	Jul 15
Tripeny R Tony	Director	Jul 14 '26	Buy	0.00	3,846	0	8,033	Jul 15
Hannigan Todd	Executive Chairman	Jul 13 '26	Buy	3.59	300,000	1,075,980	26,633,334	Jul 13
Hannigan Todd	Executive Chairman	Jul 10 '26	Buy	3.58	225,000	805,185	26,333,334	Jul 13
Martin Lorraine M	Director	Jul 10 '26	Buy	0.00	4,100	0	8,855	Jul 13
Symonds Toby Edgcumbe	President	Jul 10 '26	Buy	0.00	2,040	0	39,040	Jul 13
Arima Anastasios	Chief Executive Officer	Jul 10 '26	Buy	3.58	138,720	497,228	12,455,502	Jul 13
Symonds Toby Edgcumbe	President	Apr 28 '26	Buy	0.00	3,000	0	37,000	Apr 30
Martin Lorraine M	Director	Apr 28 '26	Buy	0.00	4,755	0	4,755	Apr 30
Arima Anastasios	Chief Executive Officer	Apr 28 '26	Buy	4.49	110,000	493,625	12,316,782	Apr 30
Hannigan Todd	Executive Chairman	Apr 29 '26	Buy	4.20	260,000	1,091,766	26,108,334	Apr 29
Hannigan Todd	Executive Chairman	Apr 28 '26	Buy	4.48	220,000	986,018	25,848,334	Apr 29
Symonds Toby Edgcumbe	President	Mar 27 '26	Buy	23.87	11,000	262,552	11,000	Mar 30
Tripeny R Tony	Director	Mar 27 '26	Buy	23.76	4,187	99,464	4,187	Mar 30
Hannigan Todd	Director	Mar 27 '26	Buy	3.20	225,225	720,923	25,628,334	Mar 30

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.